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Abstract: 
Hypertension is one of the major issues of public health in the today world that is one of the main risk factors of 
cardiovascular diseases. Current study was conducted aiming at comparative investigation of level of depression, 
anxiety, and quality of life in patients with hypertension and healthy individuals. In a case-control study, 60 patients 
with hypertension were randomly selected based on inclusion and exclusion criteria, and they were compared with 
60 of their first-degree relatives without hypertension in terms of depression symptoms. Research data were 
collected using demographic questionnaire, Beck depression inventory, Beck anxiety inventory, and WHO quality of 
life survey, and they were analyzed using descriptive statistical methods in SPSS 16 software. Independent t test was 
also used. Depression and anxiety symptoms are more in patients with hypertension compared to those without 
hypertension, and quality of life in patients with hypertension is lower than the other group. Results of this study 
showed high prevalence of anxiety and depression and low quality of life in patients with hypertension. 
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INTRODUCTION: 
Anxiety is the most common reaction to stressor. 
Anxiety means unpleasant emotions that all of us 
have experienced degrees of it in such moods as 
concern, tension and fear. Anxiety in patients with 
hypertension (HTN) has different psychological and 
physiological effects [1]. 
Anxiety-related diseases are among the most 
common diseases in modern societies. These diseases 
in the advanced countries constitute 15 – 20 percent 
of clients to clinics. Anxiety can increase the risk of 
coronary artery disease(CAD) in healthy people and 
the harmful consequences in people with CAD  
[2].Depression is the most common psychiatric 
disorder that has increased in recent years. In almost 
everyone’s life, there are times when feelings of 
frustration, sadness, disappointment, loneliness and 
dissatisfaction are overwhelming, all of which are 
common experiences of depression [3].This disorder 
may become underlying cause of other chronic 
diseases by changes in the life styles as reduction of 
physical activity, increasing smoking, increasing 
appetite, and increasing weight, and other chronic 
diseases making problem for optimal control of them 
may accompany it [4]. 
Anxiety and depression are factors for predicting and 
increasing harmful cardiac consequences in patients 
with HTN, and negligence to them may reduce 
chance for improvement of other cardiac risk factors 
[5]. HTN is one of the most common and major 
health threats, and almost one fourth of all mortalities 
in the old people results from HTN or its resulting 
consequences. Chronic HTN is a kind of common 
and asymptomatic disease that is caused by general 
or functional disorders and is called primary HTN[6]. 
Diagnosis of CAD, including HTN, in addition to 
raising physical problems, causes a significant 
disorder in patients' psychological state. Anxiety, 
depression, and uncertainty about the future are 
among these disorders [5]. HTN in addition to 
undesirable physical effects, such as atherosclerosis, 
myocardial infarction (MI), stroke, and renal 
failure(RF), can have adverse effects on the mental 
health and quality of life(QOL) of the affected 
patients [7]. 
Rabines et al. maintain HTN changes QOL in old 
people due to developing complications of 
depression, socioeconomic deficiencies [8]. Various 
studies have shown that QOL ofpatients with HTN is 
low [9]. 
Considering increasing number of patients with HTN 
in Iran and in the world, as well as adverse impacts of 
QOL on chronic diseases such as HTN, QOL in this 
group of patients is especially important. Since most 
psychological treatments pay less attention to 
improving QOL as the main medical goal, current 
research aims at indicating effect of QOL on HTN. It 
conducts a comparative study of level of anxiety, 
depression, and QOL in patients with and without 
HTN in Amiralmomenin Ali Hospital in Zabol. 
MATERIALS AND METHODS: 
This is a causal-comparative research. Research 
statistical population included patients with HTN 
who were transferred to the CardiacCare Unit(CCU) 
following reference to the clinic or emergency unit. 
Samples were selected using simple random 
sampling. Sample size in this research was 120. 
Firstly, research objectives were described to the 
participants, so that they completed the questionnaire 
with consent and voluntarily. In addition, they were 
ensured that the answers would keep confidential and 
merely would be used for research purpose. 
Measurement tool in this research was Beck anxiety 
inventory and Beck depression inventory and WHO 
quality of life survey. Sixty patients with HTN (30 
females and 30 males) were asked to complete the 
questionnaire, and 60 ones of the patients’ family 
members and relatives were matched in terms of 
gender. Descriptive and analytical statistics in SPSS 
version 16.0 were used for data analysis. 
Beck depression inventory has been used in over 
1,400 research studies, and many comprehensive 
studies have been conducted on psychometric 
properties and application of this questionnaire. It is 
used as the depression scale in most countries at a 
wide level. The questionnaire consists of 21 groups 
of depression symptoms, each of which consists of 5-
4 options. Beck test is for people over 13 years old 
and has at least six appropriate literacy classes. 
Beck Anxiety Inventory was designed for measuring 
anxiety level and includes 21 items. Each item 
reflects one of anxiety symptoms, which are often 
experienced by those who are clinicallyanxious or are 
at anxious situation. Respondent should read the list 
of symptoms and scale the severity of symptom 
within last week, and mark his evaluation in the 
columns of"At all", "mild", "moderate," and "severe." 
WHO Quality of Life Survey evaluates perception of 
people toward value and cultural systems as well as 
personal goals, standards, and worries. These are 
tools that have been used in some centers in the 
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world, and thus have been widely tested and 
examined [10]. This survey includes 26 items, which 
derived from 100-item version of this survey. It 
investigates QOL at four areas of physical health, 
mental health, social relations, and environmental 
health. 
RESULTS: 
Findings show that there is significant difference 
between two groups in terms of anxiety level (p = 
0.001, df = 58, t = 9.04), and patients with HTN 
suffers from more anxiety. 
In addition, results showed there is significant 
difference between two groups in terms of depression 
level (p = 0.001, df = 58, t = 11.39), and patients with 
HTN suffers from more depression. 
Findings indicated that there is significant difference 
between two groups in terms of QOL (p = 0.001, df = 
58, t = 9.04), and patients with HTN suffered from 
lower QOL. 
DISCUSSION AND CONCLUSION: 
There is significant difference between anxiety scores 
of men and women with HTN and without HTN in 
Zabol, which is consistent with findings in the 
following studies. 
In a study by Goldestein et al. (2007) it was found 
that HTN was higher in children of families with 
stressful parents, which did not express their anger or 
were aggressive and anxious, and the highest level 
was during working days [11]. 
In the study by Tiemin et al. (2006) on 432 women 
with HTN in a local community, anxiety symptoms 
in clinical conditions of 103 patients, with raw score 
above 40, were diagnosed. In all individuals, mean 
score in women was higher than men. Finally, it was 
found that almost 12% of patients with HTN suffered 
from symptoms of anxiety [12]. 
In the study by Jula et al. (1999), the mean arterial 
pressure in conditions such as expression of anger 
and disability in reading was high. In general, the 
results of this study showed a significant relationship 
between anxiety and anger with chronic  HTN, which 
is consistent with previous findings. In the physical 
anxiety index, the results of the study by Tiemin et al. 
[12] and ArashzadeShoorideh (1996) suggested that 
systolic and diastolic blood pressure decreases by 
relaxing and reducing physical anxiety [14]. 
According to the above results, patients with HTN 
are at risk of anxiety and there is a possibility that 
these two diseases will occur simultaneously in their 
lifetime. Considering the high frequency of anxiety in 
this study and other studies, it seems that screening of 
anxiety and psychiatric counseling should be 
considered more seriously in people with HTN. 
There is a significant difference between mean scores 
of depression in males and females in patients with 
and withoutHTN in Zabol. The results of this study 
are consistent with the following findings.  
In this study, significant relationship was reported 
between duration of suffering from HTN  and 
incidence of depression, which denotes that fact that 
increasing years of disease increases risk for 
incidence of depression in varying degrees.Fear of 
the disease complications or real incidence of these 
complications, more consumption of anti-
hypertensive drugs and side effects of these drugs 
and weakness of the patient due to gradual 
complications of HTN can be considered as possible 
factors of depression incidence over the time.Relative 
frequency of depression in patients with hypertension 
was 63%. Depression at all its three levels (mild, 
moderate, and severe) was significantly higher in the 
hHTN group compared to the control group. 
Rabkin et al. showed that relative frequency of 
depression in patients with HTN under treatment was 
three times of individuals without HTN. Patients with 
depression show less cooperation in using anti-
hypertensive drug [8]. Eraghchian et al. reported 
frequency of depression in this group of patients as 
48.6 percent [15]. There are other studies which also 
support relationship between HTN and depression 
[16]. 
In the current study, using more than one anti-
hypertensive drug was accompanied by significant 
increase in relative frequency of depression. In a 
study, it has been shown that the frequency of 
depression in consumers of more than one 
antihypertensive drug was significantly higher than 
that of those who received single anti-hypertensive 
medication, regardless of the type of drug [17]. A 
group of researchers reported that depression itself 
causes a decrease in blood pressure, but 
antidepressants increaseHTN [18]. On the other hand, 
it has been shown in a study that some 
antihypertensive drugs, such as beta-blockers, are 
responsible for depression [19]. 
These findings reapprove necessity for attention to 
psychological conditions in patients with HTN. 
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Given above findings, patients with HTN are also 
susceptible to depression, and there is a possibility 
that these two diseases will occur simultaneously in 
their lifetime. Given high frequency of depression in 
this study and other studies, it seems that screening of 
anxiety and psychiatric counseling should be 
considered more seriously in people with HTN. 
There is a significant difference between mean scores 
of QOL in males and females in patients with and 
without HTN in Zabol. The results of this study are 
consistent with the following findings. According to 
the research findings, there is significant difference in 
terms of QOL between healthy group and HTN 
group, so that quality of life was in lower level in 
patients with HTN. 
Kitler in his studies stated that HTN is a factor for 
reducing QOL due to influence on the patient’s 
physical aspects, and quality of life of patient will be 
improved if it is properly controlled [20]. Mikami et 
al. believed that HTN caused  reducing QOL due to 
different reasons such as social, psychological 
(depression), and financial deficiencies, and even 
sometimes side effects of anti-hypertensive drugs 
may also reduceQOL because of their complications 
[21]. 
Based on this research, anti-hypertensive drugs not 
only have significant impact on well-being, but also 
have positive impacts on different aspects of QOL, 
and even type of drug influences changes in quality 
of life [22]. Fogari in his study reported that HTNhas 
negative impacts on quality of life in old people, 
control of which promotes their QOL.Our findings in 
this work support negative impacts of HTN on QOL. 
Thus, investigation of HTN in old people is necessary 
and it should be taken seriously.  
Findings of current research suggest that healthy 
individuals are at higher levels of QOL. Lower QOL 
in old patients with HTN compared to healthy group 
can be justified in this way that HTN in these people 
not only reduces physiological and physical 
capacities, but also plays considerable role in 
developing complication’s as a risk factor and 
developing cardiovascular and psychological 
problems such as depression, reducing other abilities 
such as cognitive abilities, high dependence on drugs, 
and economic costs, and it may have adverse impacts 
if it is not properly controlled or treated. 
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